MYC and colorectal neoplasm: Indeed, eIF4A inhibition has been reported as a promising strategy to reduce MYC expression in colorectal tumors (Wiegering et al., 2015), and the possibility of metformin directly inhibiting eIF4A activity cannot be excluded.